奧思集團(01161.HK)預計年度股東應占純利約6500萬港元至6900萬港元
格隆匯12月4日丨奧思集團(01161.HK)公吿,根據對集團截至2024年9月30日止年度未經審核綜合管理賬目初步審閲,集團預計將錄得股東應占純利約6500萬港元至6900萬港元,而截至2023年9月30日止年度則錄得約1.1億港元。
純利減少主要由於以下因素:1)報吿年度毛利輕微上升;2)對高績效員工採取措施導致員工成本上升;3)為提升集團品牌形象,投資於高知名度及高影響力廣吿活動導致營銷開支增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.